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Little is known about innate immunity and components of inﬂammasomes in airway epithelium. This study evaluated
immunohistological evidence for NLRP3 inﬂammasomes in normal and inﬂamed murine (Balb/c) airway epithelium in a model
of ovalbumin (OVA) induced allergic airway inﬂammation. The airway epithelium of control mice exhibited strong cytoplasmic
staining for total caspase-1, ASC, and NLRP3, whereas the OVA mice exhibited strong staining for active caspase-1, with
redistributionofcaspase-1,IL-1β andIL-18,indicatingpossibleactivationoftheNLRP3inﬂammasome.Activecaspase-1,NLRP3,
and other inﬂammasome components were also detected in tissue eosinophils from OVA mice, and may potentially contribute to
IL-1β and IL-18 production. In whole lung, inRNA expression of NAIP and procaspase-1 was increased in OVA mice, whereas
NLRP3, IL-1β and IL-18 decreased. Some OVA-treated mice also had signiﬁcantly elevated and tightly correlated serum levels of
IL-1β and TNFα. In cultured normal human bronchial epithelial cells, LPS priming resulted in a signiﬁcant increase in NLRP3 and
II-lp protein expression. This study is the ﬁrst to demonstrate NLRP3 inﬂammasome components in normal airway epithelium
and changes with inﬂammation. We propose activation and/or luminal release of the inﬂammasome is a feature of allergic airway
inﬂammation which may contribute to disease pathogenesis.
1.Introduction
Asthma aﬀects up to 12% of adults and 25% of children
in Australia and there is a signiﬁcant undiagnosed cohort
[1]. Although we have a range of medications that are eﬀec-
tive in their own right, there is a need to further improve the
management of this disease. This involves better clinical pro-
grams and an improved understanding of the basic mecha-
nisms of asthma so that new ways can be introduced which
work synergistically with conventional asthma medications
to modify airway inﬂammation.
Asthma is a disease characterized by both bronchiolar
smooth muscle constriction and a chronic airway inﬂamma-
tion. Some of the features of the disease are modelled in2 Journal of Allergy
the well-characterized acute and chronic models of OVA-
induced allergic airway inﬂammation in mice [2, 3]. The
inﬂammatory component of asthma is generally thought of
as a Th2-driven process, involving eosinophil recruitment to
the airways and consequent damage, including airway epi-
thelial cell death [4]. Damage and repair eventually lead to a
remodelling of the airways which increases the sensitivity of
the airway muscle to cholinergic agonists and further restri-
cts airﬂow.
However, other inﬂammatory signalling pathways may
also play a signiﬁcant role in the pathogenesis and progres-
sion of the disease. Of particular interest is the role of the IL-
1 family of cytokines that are key components of the innate
immuneresponse[5].IL-1βandIL-18areactivatedbycytos-
olic multiprotein complexes called inﬂammasomes [6, 7].
Inﬂammasomes have been best characterized in the mono-
cyte-macrophage cell lineage, but recent evidence indicates
that gingival (and perhaps other) types of epithelial cells
may also contain these structures [8]. Their generic struc-
ture includes (i) a member of the nucleotide-binding oligo-
merization domain- (NOD-) like receptor (NLR) family
of pattern recognition molecules speciﬁc for each type of
inﬂammasome, (ii) apoptosis-associated speck-like protein
containing a caspase-recruitment domain (ASC), and (iii)
caspase-1. Other inﬂammatory caspases or caspase-regula-
tory molecules such as X-linked or neuronal inhibitor of
apoptosis proteins, XIAP and NIAP, respectively, may also
be recruited. Diﬀerent types of inﬂammasome (e.g., Nlrp1,
Nlrp3, IPAF, and AIM2) have been identiﬁed based on the
NLR component (or the non-NLR equivalent) which forms
the complex. Of these the best characterized is the Nlrp3
inﬂammasome which plays a predominant role in IL-1β
and IL-18 production [7]. In macrophages, IL-1β produc-
tion, processing, and release requires the interaction of two
signalling pathways. Binding of ligands such as lipopolysac-
charide (LPS) to membrane toll-like receptor 4 (TLR-4)
triggers the synthesis of pro-IL-1β while a number of danger
signals including molecules released from necrotic cells
(e.g., ATP and uric acid) promote assembly of the Nlrp3
inﬂammasome complex, activation of caspase-1 from its
precursor, processing of IL-1β to its active form, and release
of IL-1β from the cells [8].
Inﬂammasome involvement in asthma inﬂammation is
a relatively new concept. An early protective role for inﬂam-
masomes might be predicted by the “hygiene hypothesis”,
whereby exposure to microbes and their products (such as
LPS)earlyinlifeisthoughttoprotectagainstdevelopmentof
asthma, perhaps by a skewing of the immune response away
from one dominated by Th2 cytokines [9]. However, cur-
rent evidence would favour a proinﬂammatory role for
IL-1β since (i) there are increased levels of serum, BALF,
and bronchial epithelial IL-1β in human asthmatics, com-
pared to healthy subjects [10–12], (ii) increase in serum
IL-1β has also been reported in primates [13], (iii) IL-1β
levels were decreased 2-fold in the bronchial epithelium fol-
lowing inhalation of beclomethasone dipropionate (as meas-
ured by an immunohistological technique) [14], and (iv)
administration of TNF-α and IL-1β induces airway hyper-
reactivity, a feature of asthma [15, 16]. IL-18, another potent
pro-inﬂammatory cytokine whose maturation requires
activation of caspase-1 on the inﬂammasome, is typically
considered as a Th1 cytokine due to its eﬀects associated
with IFN-γ. Increased serum IL-18 has also been described
in asthmatics [17–19]. Finally, danger signal molecules such
as uric acid and extracellular ATP have been shown to medi-
ateinﬂammasome-dependentinﬂammationinexperimental
rodent models of lung injury [20] and asthma [21], res-
pectively.
In addition to providing a physical barrier to inhaled
pathogens, allergens, and other foreign agents, the airway
mucosa (epithelium and secretions) has a number of poten-
tialmechanismsbywhichitcancontributetoinnateimmune
defences in the lung. Loss of the integrity of the airway epith-
elium is widely thought to be a critical component in the
pathogenesis of asthma [22]. To our knowledge, there has
beennosystematicstudyoftheinﬂammasomeinairwayepi-
thelium. In this study, we have looked for evidence of Nlrp3
inﬂammasome involvement in OVA-induced airway inﬂam-
mation in mice, as a model of human asthma, as well as in
primary bronchial epithelial cultures.
2.MaterialsandMethods
2.1. Antibodies. Rabbit polyclonal antibodies (Abs) to IL-1β,
Nlrp3, total caspase-1; goat Abs to caspase-1 P10 and P20
active subunits; and mouse monoclonal Ab (mAb) to SP-D
werefromSantaCruzBiotechnology(SantaCruz,CA,USA).
Other rabbit Abs were ASC from Abcam (Cambridge, UK),
CCR3 from Epitomics (Burlingame, CL, USA), and IL-18
from Rockland (Gilbertsville, Pennsylvania, USA). Mouse
mAb to human NLRP3 was from Enzo (Enzo Life Sciences
Inc., Farmingdale, NY, USA). Secondary Abs were sheep
F(ab )2 anti-rabbit IgG (Cy3), goat F(ab )2 anti-rabbit IgG
(FITC), rabbit anti-goat IgG (Cy3), sheep F(ab )2 anti-
mouse IgG (Cy3), (Sigma-Aldrich Chemicals, St Louis, MO,
USA), and a donkey F(ab )2 anti-mouse IgG DyLight594
(Jackson ImmunoResearch, West Grove, PA, USA).
2.2. Mouse Model of Allergic Airway Inﬂammation. A clas-
sical mouse model [23] that induces strong eosinophilic
inﬂammation, airway hyper-responsiveness, and vascular
and parenchymal changes after sensitisation and challenge
with OVA was used to induce inﬂammation. All experiments
were performed under the University of Adelaide Animal
Ethics Committee approval number M-57-2007, and in
compliance with “Principles of Animal Care” publication
number 86-23 of the National Institute of Health and the
“Australian Code of Practice for the Care and Use of Animals
for Scientiﬁc Purposes”, 6th Edition.
Female Balb/c mice (age 4–6 weeks; speciﬁc pathogen
free) were purchased from the University of Adelaide,
Adelaide, Australia. Three mice were set aside for analysis of
inﬂammasome components in the absence of any stimulus.
The remaining mice were divided into two experimental
groups (n = 8 in each group) and housed in plastic cages
(38 × 25cm) at 21◦C with a 14h light/10-h dark cycle.Journal of Allergy 3
OVA-treated mice received 50μgo fc h i c k e nO V Ai n1m Lo f
alhydrogel (CSL, Parkville, Australia) in 0.9% sterile saline,
i.p. ondays0 and14. Control (SAL)micereceivedalhydrogel
in 0.9% saline alone. Mice sensitized to OVA were then
aerochallenged with 10mg/mL OVA in 0.9% saline from day
22 to day 32, for 30min, three times a day, every 2nd day,
using a side-stream nebulizer, which produced particles of
1–3μm (Fisher and Paykel, Sydney, Australia). SAL-treated
groups were nebulised with 0.9% saline alone.
2.3. Collection of Tissues. Mice were bled from the tail
for preparation of sera. For tissue collection, mice were
anaesthetized by an i.p. dose of pentobarbitone sodium
(50mgkg−1),22hafterthelastnebulization.Thetracheawas
cannulatedwithablunted19-gaugeneedleandbronchoalve-
olar lavage ﬂuid (BALF) was collected by lavaging the lungs
three times by instilling and withdrawing the same volume
( 1m L )o fi c e - c o l dH a n k sb u ﬀered salt solution (HBSS, pH
7.4).OnepartoftheBALFsamplewasimmediatelycytospun
onto slides and the other part was centrifuged to obtain su-
pernatant for cytokine and uric acid assay. Mice were then
sacriﬁced and other tissue samples collected. Tissue samples
werearchivedasappropriateforvariousdownstreammeasu-
rements, including standard assessments of airway and tissue
eosinophilia and lung histopathology.
2.4. Isolation of Lung mRNA and Reverse Transcription. Sam-
ples of mouse lung tissue were immediately placed into
RNA later (Applied Biosystems/Ambion, USA). Tissue was
homogenized using a TissueRuptor (Qiagen Pty Ltd, Aus-
tralia) and RNA extracted using an RNeasy Mini Kit (Qiagen
Pty Ltd, Australia). An on-column DNAse treatment was
performed using an RNase-Free DNase Set (Qiagen Pty Ltd,
Australia). RNA quality was checked using an Experion RNA
StdSens Kit on the Experion Electrophoresis station (BioRad
Laboratories Inc, Australia). Mouse RNA samples obtaining
RQI of 7–10 (green) were used in the subsequent array ana-
lysis. RNA content was quantiﬁed using a Nano Drop 1000
Spectrophotometer (Thermo Scientiﬁc, USA). 1000ng of
RNA was reverse transcribed into cDNA using the RT2 First
Strand Kit (Qiagen Pty Ltd, Australia). The incubation steps
for the reaction were performed on a MyCycler Thermal Cy-
cler (BioRad Laboratories Inc, Australia).
2.5. Real-Time Quantitative PCR Array. M o u s ec D N As a m -
pleswerecombinedwithRT2 SYBRGreen/FluoresceinqPCR
Master Mix with Nuclease-free Sterile H2O (Qiagen Pty Ltd,
Australia) and then added across an entire RT2 Proﬁler PCR
Mouse Inﬂammasome Array (PAMM-097A) 96-well plate.
Each mouse sample (n = 8 from each group) was tested on
a separate 96-well array plate containing a panel of 84 wells
pertaining to diﬀerent genes of the inﬂammasome pathway,
5 house keeping control wells, 1 genomic DNA control well,
3 reverse transcription control wells, and three positive PCR
control wells. PCR was performed using an iCycler with
iQ5 Software (BioRad Laboratories Inc, Australia) and Cq
data was then analysed by the ΔΔCt method using the RT2
Proﬁlier Array data spreadsheet (Qiagen Pty Ltd, Australia).
2.6. Measurement of Cytokines. Serum cytokines were mea-
sured by Bioplex as per the manufacturer’s instructions (Bio-
Rad Laboratories Inc, Australia). In brief, the concentration
of total protein per sample was determined by Mini Bradford
assay (BioRad Laboratories Inc, Australia) using standards of
bovine serum albumin (Sigma-Aldrich Chemicals, St Louis,
MO, USA). Samples were normalised to 100μg total pro-
tein and analysed in duplicate using a Bioplex Promouse Cy-
tokine 8 plex magnetic bead array. All wash steps were per-
formed using the Bioplex II Wash Station. Plate data was col-
lected using a Bioplex 200 suspension array system and ana-
lysed using the Bioplex Manager 5 Software (BioRad Labora-
tories Inc, Australia).
2.7. Immunoﬂuorescence Studies. Paraﬃnt i s s u es e c t i o n so f
5μm thickness were treated for antigen retrieval by micro-
waveheatingin10mMcitratebuﬀerpH6.0unlessotherwise
stated. Tissue sections were also heated in 10mM Tris EDTA
buﬀer pH 9.0 for costaining of SP-D with caspase-1, and
digested with 1mg/mL Proteinase K (Promega, Fitchburg,
Wisconsin, USA) for staining of P10 and P20 caspase-1 sub-
units.Sectionswereblockedwithaserum-freeproteinblock-
ing solution (DakoCytomation Inc., Carpinteria, CA, USA),
incubated overnight at 4◦Cw i t hp r i m a r yA b s ,a n d1 ha t
roomtemperaturewithsecondaryAbs.Immunoﬂuorescence
was detected and imaged with a Zeiss microscope equipped
with HBO 100 illuminating system, AxioCam MRn digital
camera and AxioVision 4.8.1 software (Carl Zeiss GmbH,
Goettingen, Germany).
2.8. TUNEL Staining of Cell Death. Cell death was detected
insituusingaﬂuorescenceTUNELkitfromPromega(Fitch-
burg, Wisconsin, USA) following the manufacturer’s proto-
col.
2.9. Measurement of Uric Acid in BALF. Uric acid was meas-
ured in BALF according to manufacturer’s instructions using
the Amplex Red Uric Acid/Uricase Assay Kit (A22181, Invit-
rogenAustPtyLtd,Mulgrave,Australia).Fluorescencemeas-
urements were made using a ﬂuorescence plate reader (Opti-
ma Fluostar, BMG Labtech, Gmbh, Oﬀenburg, Germany)
with excitation at 530nm and emission read at 590nm.
2.10. Normal Human Bronchial Epithelial Cell Culture. Nor-
mal human bronchial epithelial (NHBE) cells and Bronchial
Epithelial Growth Medium (BEGM) were obtained from
Lonza (Lonza Australia Pty Ltd, Mt Waverley, VIC, Aus-
tralia). Cells were cultured in BEGM until use at passage 4.
Cells at 60–70% conﬂuence were stimulated for 18h with E.
coli LPS (5μg/mL, Sigma-Aldrich Chemicals, St Louis, MO,
USA), IFN-γ (50ng/mL, Sigma-Aldrich Chemicals, St Louis,
MO, USA), or combination of these two, in 8-well chamber
slides (BD Biosciences, Franklin Lakes, NJ, USA). Cells were
washed twice with phosphate-buﬀered saline (PBS) and then
ﬁxed with 2.5% formalin/PBS for 10 minutes. Cells were
washed4timeswithTBST(tris-buﬀeredsaline,pH7.5added
with 0.05% Tween-20), air-dried overnight at room tem-
perature, and stored at −20◦C until use.4 Journal of Allergy
2.11. Immunoﬂuorescence of NHBE. Fixed cells were perme-
abilized 5 minutes with 1% SDS/PBS at room temperature,
then washed 5 times with TBST to remove SDS. Following
1h blocking incubation with a serum-free protein blocker
(DakoCytomation Inc., Carpinteria, CA, USA), cells were
incubated with a mixture of primary antibodies (see anti-
body sectionofmethods) including mousemonoclonal anti-
body to human Nlrp3 and a rabbit polyclonal anti-human
IL-1β, overnight at 4◦C. Next, following 5 washes with TBST,
cells were incubated 1h at room temperature with a mixture
of secondary antibodies including a donkey F(ab )2 anti-
mouse IgG DyLight594 and goat F(ab )2 anti-rabbit IgG-
FITC. Slides were washed 5 times with TBST before cover-
slipping and imaging.
For quantitation of ﬂuorescence intensity, multiple
microphotos were acquired randomly under a 20x objective.
Images were then blinded and analysed using a morphomet-
ric software package (ImageJ, NIH, Bethesda, MD, USA).
3. Results
3.1. Parameters of Airway Inﬂammation. In keeping with
previous descriptions of the acute allergic airway inﬂam-
mation model [2, 23], the airway inﬂammation in OVA-
challenged mice was characterized by dense peribronchial
andperivascularinﬁltratesofleucocytes(mostlyeosinophils)
and oedema of bronchial epithelium. Epithelial swelling was
more prominent in large bronchi that were sometimes oc-
cluded by thickened epithelium. There was swelling of endo-
thelial cells in some blood vessels. No increase of mast cells
wasdetected.Noneofthesaline-(SAL-)treatedmiceshowed
anynotablehistological changes.Typically, therewasa 7-fold
increase in total BALF cell count from 15.6 ± 11.1 × 104
(median ± 2.5% CI) cells/mL in SAL controls to 117.7 ±
82.7 × 104 cells/mL in OVA-treated mice (P<0.0001).
This was largely due to eosinophilia (>85%), although num-
bers of neutrophils, monocytes, and lymphocytes were also
signiﬁcantly increased (P<0.05, data not shown).
3.2. Presence of Inﬂammasome Components in Normal Mouse
Airway Epithelium. To test the hypothesis that the normal
airway epithelium possesses the ability to assemble inﬂam-
masome complexes, we used immunoﬂuorescence to analyse
formalin-ﬁxed lung tissue sections obtained from healthy
Balb/c mice for expression of inﬂammasome common com-
ponents Nlrp3, ASC and caspase-1, and the substrate cyto-
kines IL-1β and IL-18. The same results were obtained for
completely untreated mice (naive mice, n = 3) and SAL mice
(n = 8) that were sham-treated with saline i.p. injections and
saline nebulisation and used as controls in the experimental
murine airway inﬂammation model.
Serial sections of control mouse lungs (n = 8) were
examined by immunohistological labelling for caspase-1 and
various other inﬂammasome-related proteins. Figures 1(a)–
1(c) show colocalization of caspase-1 and Nlrp3 in the
epithelia of three bronchioles. The ﬂuorescence staining for
caspase-1 could be speciﬁcally blocked with the relevant
immunogen peptide (Figure 1(c)). Blocking peptides were
not available for the other antibodies in this panel. However,
omission of primary antibody or section incubation with
normal rabbit IgG (at matched IgG concentrations) resulted
in negligible ﬂuorescence (Figure 1(f)). Colocalization of
caspase-1 and Nlrp3 with IL-1β, IL-18, and ASC in bron-
chiolar epithelia was shown (Figures 1(d)–1(k)). There was
also colocalization in certain cells scattered among alveoli.
It should be noted that the antibodies to caspase-1, IL-1β,
and IL-18 did not distinguish between their precursor and
mature forms. After performing immunoﬂuorescence, some
sections were washed and restained with hematoxylin and
eosin (H&E) to examine morphology. Figures 2(a) and 2(b)
show low and high magniﬁcation images of a section of
the normal mouse lung immunolabelled for caspase-1, while
Figures 2(c) and 2(d) show the corresponding H&E restain-
ing. The caspase-1 positive-staining cells around the alveoli
were identiﬁed as both alveolar macrophages localised in
the alveolar air space (e.g., arrowed cell in Figure 2(D1))
and type 2 alveolar cells (ATII) typically seen at alveolar
junctions and showing lamellar bodies in the cytoplasm
(Figures 2(D2) and 2(D3)). The identity of these two cell
types was conﬁrmed by dual labelling of caspase-1 with
either F4/80 (a marker of mouse macrophages, Figure 2(e))
or SP-D (a marker of ATII, Figure 2(f)).
Thus, the normal murine airway epithelium (bronchial
epithelium and ATII) expresses, at the protein level, inﬂam-
masome components Nlrp3, ASC, and caspase-1, as well as
the substrate cytokines IL-1β and IL-18.
3.3. Presence of Active Caspase-1 in Inﬂamed, but Not Normal,
Mouse Airway Epithelium. The antibody for caspase-1 used
in the previous series of experiments did not diﬀerentiate
between the inactive precursor and active form. Using anti-
bodies speciﬁc for the cleaved ends of P10 and P20 subunits
of caspase-1, we were able to demonstrate very low levels or
absence of active caspase-1 in the control mouse lung epi-
thelium (Figure 3(a)). In contrast, distinct patterns of active
caspase-1 staining were detected in the epithelium of the
inﬂamed airways of OVA-treated animals (Figures 3(b)–
3(d)). In adjacent serial sections of inﬂamed lung, the two
diﬀerent antibodies P10 and P20 revealed the same punctate
patterns of caspase-1 activation near the epithelial apical sur-
face (Figures 3(c) and 3(d)). Preabsorption with the relevant
immunogen peptides reduced the labelling of active caspase-
1 in the inﬂamed airway epithelium to a level comparable to
thatoftheconjugatealone(Figures3(e)–3(g)).Becausethere
are inherent problems in trying to quantify actual changes in
ﬂuorescence intensity where there is a redistribution of the
label within the treatment accompanying the induction of
inﬂammation, we have not attempted to quantify changes in
intensity of immunoﬂuorescence for the various proteins in
these sections.
These results suggest that inﬂammation of the airways
in mice is accompanied by conversion of zymogen caspase
1 to its active form and a more apical distribution of inﬂam-
masome proteins.
3.4. Translocation and Luminal Shedding of the IL-1 Cytokines
andInﬂammasomeProteinsinAllergen-InducedInﬂamedAir-
way Epithelium. As mentioned earlier, our antibody panelJournal of Allergy 5
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k)
Figure 1: Expression of inﬂammasome proteins and the IL-1 cytokines in normal mouse lung epithelium. (a–c) Serial sections showing
positive labelling for Nlrp3 (a) and total caspase-1 (b) in epithelia of three bronchioles; labelling for caspase-1 was blocked by speciﬁc
peptide. No blocking peptide for Nlrp3 was available. (d–k) Serial sections showing positive and colocalized labelling of Nlrp3 and caspase-1
(d-e, red), Nlrp3, IL-1β, and IL-18 (g–i, red), and caspase-1 and ASC (j-k). (f) Negligible ﬂuorescence was detected using normal rabbit IgG
as a negative control for Nlrp3 and all other rabbit antibodies employed in this panel. Blue is DAPI counterstaining of nuclei. Images are
representative of similar results from 8 control mice challenged with saline and 3 naive mice. The scale bars are in microns.
did not diﬀerentiate between the inactive precursors and the
mature (active) forms of IL-1β and IL-18 cytokines. How-
ever, there were diﬀerent patterns of IL-1β and IL-18 distri-
bution demonstrated by immunoﬂuorescence between the
epithelia of OVA-treated and control mice (Figure 4). In the
healthy epithelium, both cytokines distributed more or less
homogeneously in the cytoplasm (Figures 4(a) and 4(b)). In
contrast, in the inﬂamed airways, the immunoﬂuorescence
of the IL-1 cytokines had a more speckled appearance at
the apical surface of the epithelium (Figures 4(c) and 4(d)
arrows). Furthermore, immunoﬂuorescence of both IL-1β
a n dI L - 1 8c o u l db ed e t e c t e di nt h el u m e n( F i g u r e s4(c)
and 4(d), arrowheads). Similarly, luminal staining near the
apical surface was also detected for caspase-1 (Figures 4(e)
and 4(k)), Nlrp3 (Figure 4(i)), and ASC (not shown).
When labelled sections of inﬂamed mouse lungs were res-
tained with H&E (Figures 4(g)–4(l)), part of the luminal ﬂu-
orescence of the cytokines and inﬂammasome proteins was
localized to inﬁltrating leukocytes (mostly eosinophils) or
well preserved cell bodies (∼6–10μm in diameter) often seen
embedded in the mucus near the epithelial apex (Figure 4(h)
and 4(l) insets). It is unlikely that the luminal staining was
an artefact caused during tissue processing. Tissues were im-
mediately ﬁxed in formalin for paraﬃn embedding and the
luminal staining was consistently observed in tissue sections,
including serial adjacent sections (e.g., Figures 3(c) and 3(d),
Figures 4(c)–4(e), with Figure 4(f) as negative control), in all
of the mice tissues analysed.6 Journal of Allergy
(a) (b)
(c) (d)
(e) (f)
(D1) (D2) (D3)
Figure 2: Identiﬁcation of cell types expressing caspase-1 in normal mouse lung. (a) Representative immunoﬂuorescence image of a normal
lung section showing total caspase-1 localized to bronchiolar epithelium as the most distinct site, as well as cells scattered among alveoli
(b). (c) and (d) Corresponding images of (a) and (b) following restaining with H&E. Caspase-1 positive cells included alveolar macrophages
(D1)ortypeIIalveolarcells,typicallyfoundatthealveolarinterseptaljunctionsandcontainingvacuole-likelamellarbodiesinthecytoplasm
(D2, D3). (e) Dual labelling of a lung section for the macrophage marker F4/80 (red) and total caspase-1 (green), revealing colocalization
(yellow) in macrophages (inset). (f) Dual labelling of a lung section for surfactant protein D (SPD, red) and caspase-1 (green), revealing
colocalization in type II alveolar cells (inset). Scale bars are in microns.
3.5. Inﬂammasome Components in Other Relevant Airway
Tissues of Mice with Airway Inﬂammation. Immunostaining
of consecutive adjacent tissue sections with caspase-1 and
CCR3, a marker of eosinophils, showed colocalization of
CCR3 with caspase-1, detected by antibodies to either the
totalortheactiveformsofthecaspase(notshown).AsCCR3
isnotaspeciﬁcmarkerofeosinophilsbutcanalsobeexpress-
edinsomeothercelltypes,immunolabelledsectionswerere-
stained by H&E to identify the type of inﬁltrating cells posi-
tively stained for inﬂammasome components. In accordance
with our previous results >80% of these cells were eosino-
phils which inﬁltrated both the submucosal tissue and the
airway lumen (Figures 4(h)–4(l)).
Another cell type which might contribute to inﬂamma-
some activation in the OVA-induced airway inﬂammation
modelisthevascularendothelium.Whereasinsaline-treatedJournal of Allergy 7
(a) (b)
(c) (d)
(e) (f) (g)
Figure 3: Activation of caspase-1 in inﬂamed airway epithelium of OVA-treated mice. Antibodies speciﬁc to cleaved ends of caspase-1 P20
or P10 subunits were employed to detect activation of caspase-1 in mouse lung tissue. (a) The normal airway epithelium typically expressed
little active caspase-1. (b) In the inﬂamed airway, the swollen epithelium (arrowheads) labelled positively for active caspase-1 as shown by
the punctate ﬂuorescence of P20 near the apical surface. (c) and (d) Adjacent serial sections of an inﬂamed lung stained for antibodies to
P20 and P10, respectively, revealed the same punctate patterns of caspase-1 activation near the apical surface. (e–g) In serial sections of an
inﬂamed lung, ﬂuorescence of P20 active caspase-1 antibody (e, red) was inhibited nearly completely by preabsorption of the antibody with
the relevant immunogen peptide (f), to a level comparable to that of the conjugate alone control (g). Blue: DAPI counterstaining of nuclei.
Images (a-b) are representative of results from P20 staining experiments on multiple sections obtained from 8 control saline-treated mice
and 8 OVA-treated mice. Colocalization of P20 and P10 staining (c-d) and P20 peptide blocking experiments (e-f) were carried out on serial
sections obtained from 4 inﬂamed lungs. Scales are in microns.
mice the vascular endothelium stained weakly for total cas-
pase-1, it often stained strongly in the lungs of OVA-treated
mice (data not shown). Unfortunately, we could not apply
the antibodies to active subunits of caspase-1 to study activa-
tion of endothelial caspase-1, due to the nonspeciﬁc binding
of these antibodies to red blood cells, which was not block-
ed by the speciﬁc peptides (data not shown). The expression
of total caspase-1 protein in inﬂamed but not healthy endo-
thelium was completely removed by blocking with speciﬁc
peptide (data not shown).8 Journal of Allergy
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Figure 4: Translocation and luminal shedding of the IL-1 cytokines and inﬂammasome proteins in inﬂamed airway epithelium. (a–f) Serial
sections of a control mouse lung (a-b) and those of an OVA-treated mouse (c–f) were stained for the cytokines and total caspase-1 in red
(Cy3), and counterstained for nuclei with DAPI (blue). In the control mouse lung epithelium, IL-1β (a), IL-18 (b), and total caspase-1
(not shown) typically gave an homogenous cytoplasmic ﬂuorescence (insets). In staining of multiple sections from the lung of OVA-treated
mice, punctate ﬂuorescence of both cytokines was consistently detected near the apical surface (c-d, insets). Together with caspase-1, these
cytokines were detected in the lumen (c, d, e, arrowheads). (f) Control section incubated with the secondary antibody alone. Fluorescence
images are representative of similar results from 3 experiments on 8 control and 8 OVA-treated mice. The scale bars are in microns. (g–
i) Fluorescently labelled sections of inﬂamed lungs (g, i, k) were restained with H&E (h, j, l) to identify luminal structures containing
inﬂammasome components and cytokines. Although some ﬂuorescence was localized to inﬁltrating eosinophils (arrowheads) or cell-free
debris (short arrows), most of the luminal shed material appeared to be within well-preserved eosinophilic vesicles (∼6–10 microns) near
the airway epithelial apex (inset long arrows). H&E images are representative of results from experiments carried out on multiple sections of
4 OVA-treated mouse lung. The scale bars are in microns.
3.6. Eﬀects of Mouse Airway Inﬂammation on Whole Lung
GeneExpression. Tolookattheeﬀectofairwayinﬂammation
on expression of gene products with relevance to the inﬂam-
masome, we analysed mRNA from lungs of SAL and OVA-
t r e a t e dm i c eb ys u p e r a r r a y( Table 1). Typically, there were
large increases (8–10 fold) in chemokines (Ccl12, Ccl7, and
Cxcl3) known to be important in the mouse airway inﬂam-
mation model. There were also signiﬁcant increases with
OVA-treatment in expression of a Th2 cytokine IL-6. For
the IL-1-like family members, there was a 2.5-fold increase
in gene expression for IL-33 and 2- and 11-fold decreases in
those for IL-1β and IL-18, respectively.
Of the gene products involved in inﬂammasome regula-
tion,thelargestchangewasan8-foldincreaseintheneuronal
inhibitorofapoptosisproteinNAIP,followedbyanalmost4-
fold decrease in Nlrp3 expression. Small signiﬁcant increases
were seen for ASC, caspase-1, and AIM2. There were no sig-
niﬁcant changes in expression of Nlrp1 and Nlrp4 (Table 1).
3.7. Cell Death and Uric Acid Levels in Airway Epithelium. In
accordance with our previous data [23], using the TUNEL
assay we conﬁrmed an increased cell death in the lung sec-
tions of OVA- versus SAL-treated animals (data not shown).
An analysis of BALF in the asthmatic mice demonstrated a
signiﬁcantincreaseinuricacid(Figure 5(a)),whichisknown
as both a product of nucleic acid catabolism in dead cells and
a stimulus for Nlrp3 inﬂammasome activation [20].
3.8. Cytokines in BALF and Serum. We were unable to detect
IL-1β and IL-18 in the BALF of either saline- or OVA-treated
mice (data not shown). This may be due to excessive dilution
of the BALF during the lavage or choosing the wrong time-
point (22hr after ﬁnal challenge) for lavaging.
Analysis of the sera showed high levels (>200pg/mL) of
IL-1β in 4 of the 8 OVA-treated mice but in none of the 8
saline-treated control mice. The serum levels of IL-1β were
tightly correlated with those of TNF-α (r = 0.95), suggestingJournal of Allergy 9
Table 1: Ovalbumin-induced changes at mRNA level in mouse lung.
Gene product∗ Relevance Ratio∗∗ OVA/SAL P value∗∗∗
Ccl12 Chemokine of CC family which attracts
eosinophils and monocytes 10.64 0.008
Ccl7 Chemokine of CC family which attracts
monocytes and regulates macrophage function 8.98 0.018
NAIP 1 (neuronal apoptosis
inhibitor protein)
Endogenous caspase inhibitor which binds to
the inﬂammasome in neuronal and
nonneuronal cell types
8.57 0.000
Cxcl3 CXC chemokine which controls migration and
adhesion of monocytes 8.31 0.016
IL-6 Th2 cytokine which promotes airway
inﬂammation in mice 3.08 0.050
IL-33 IL-1 like cytokine which mediates eosinophilia
in mouse asthma model 2.54 0.001
ASC Adaptor protein which recruits caspase-1 to the
NLRP3 complex 2.11 0.001
Caspase 1 When activated, it processes pro-IL1b and
pro-IL18 to mature cytokines 2.07 0.000
Aim2 (absent in melanoma gene 2)
Component of the AIM2 Inﬂammasome which
activates caspase-1 independent of NLR
proteins
2.00 0.002
NLRP1a Component of the NLRP1 Inﬂammasome
which activates caspases 1 and 5 1.07 0.658
NLRC4 (IPAF) Component of the NLRP4 Inﬂammasome
which mediates response to S. typhimurium 0.90 0.434
IL-1β Member of IL-1 family of cytokines 0.48 0.003
NLRP3 Component of the NLRP3 Inﬂammasome
which activates caspases 1 0.28 0.000
IL-18 Member of IL-1 family of cytokines 0.09 0.000
∗Data from a superarray experiment on lung RNA from 8 SAL and 8 OVA-treated mice. Genes relevant to the asthma/inﬂammasome pathways are shown.
∗∗Fold up- or downregulation for OVA-treated mice relative to saline-treated mice was determined by the ΔΔCt method. Ratios are in decreasing order;
ratios >1 represent increased expression with airway inﬂammation and ratios <1 represent decreased expression with airway inﬂammation. Upregulation of
Caspase-1 and downregulation of IL-1β were also conﬁrmed by an “in-house” RT-PCR assay. ∗∗∗Student T-test.
systemiceﬀectsinthismodelofallergicairwayinﬂammation
(Figure 5(b)).
3.9. Low Expression of Nlrp3 and IL-1β in Normal Human
Bronchial Epithelial Cultures and Up-regulation by LPS but
Not by IFN-γ. Commercially available passage 4 primary
cultured normal human bronchial epithelial (NHBE) cells
were studied for expression of the Nlrp3 and IL-1β proteins,
before and after priming with LPS (5ug/mL) or IFN-γ
(50ng/mL). Nlrp3 and IL-1β proteins were quantiﬁed in the
samecellbydual-labellingwiththerespectiveantibodies(see
methods) and using imageJsoftwaretoquantifyﬂuorescence
intensities. Between 26 and 51 cells (pooled from three ran-
domly acquired images for each treatment) were analysed
simultaneously for both proteins. Cells grown either in the
absence of both agents or with IFN-γ alone expressed low
levels of intracellular Nlrp3 and IL-1β as detected by immu-
noﬂuorescence (and quantiﬁed using ImageJ software).
Overnight stimulation with LPS or LPS plus IFN-γ resulted
insigniﬁcantincrease(P<0.05)ofbothNlrp3(∼2fold)and
IL-1β (4-5 fold, Figure 6).
4. Discussion
This study provides the ﬁrst evidence for presence of pre-
cursor components of the NRLP3 inﬂammasome in normal
murine airway epithelium and some other resident or
inﬂammatory airway cells. It also shows qualitative changes
in the distribution of these markers, including appearance
of active caspase-1, during airway inﬂammation in the acute
mouse OVA model. Further studies are warranted to esta-
blish the functional signiﬁcance of inﬂammasome activation
as well as links between inﬂammasome regulation and other
known mechanisms in asthma such as Th2 responses, IgE
production, and its ﬁxation on innate immune cell surfaces,
eosinophilia, and airway tissue remodelling.
Our ﬁndings suggest a role for inﬂammasomes in innate
immune responses of the airway epithelium and reinforce
the hypothesis that airway epithelium plays a sentinel role in
the innate immune response to inhaled microbes, allergens,
and other pathogens. In particular, we have shown that the
components necessary for mounting of a rapid protective
inﬂammatory response via inﬂammasome activation are all10 Journal of Allergy
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Figure 5: Increase of uric acid in BALFs (a) and cytokines IL-1β
and TNF-α in sera (b) of OVA-treated mice, compared to saline-
treated controls. (a) Box plot (showing median, interquartile range,
and nonoutlier range) demonstrating that BALF uric acid levels are
elevated in OVA-treated mice (n = 8) compared to SAL mice (n =
8), P<0.001 (Kruskal-Wallis test). (b) Scatter plot of serum IL-1β
versus TNF-α levels (pg/mL) in OVA-treated mice (open triangles,
n = 8) versus SAL-treated mice (closed triangles, n = 8). High
cytokinelevelswereonlyobservedintheOVA-treatedmousegroup.
expressed in the murine airway epithelium prior to inﬂam-
matory stimulation. Of interest, IL-1β and IL-18 were both
expressed intracellularly within the normal murine airway
epithelium. A similar expression of IL-1β w a sd e t e c t e di nr a t
lungepitheliumtissue(datanotshown).Thefailuretodetect
IL-1β in the circulation of the control mice suggests either
that airway epithelium contributes very little to blood IL-1β
levelsorthatsignalsleadingtoreleaseofIL-1β (andprobably
also IL-18) are absent from normal airway epithelium. Our
ﬁnding of intracellular IL-1β and IL-18 is therefore in
keeping with the hypothesis that the airway epithelium is
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Figure 6: Induction of IL-1β and Nlrp3 protein expression in
primary cell cultures of normal human bronchial epithelium by
proinﬂammatory stimulus. Normal human bronchial epithelial
(NHBE) cells were cultured without stimuli (control), or in pres-
ence of 50ng/mL IFN-gamma (IFN), or 5ug/mL E coli lipopolysac-
charide (LPS), or their combination (IFN + LPS). Top and middle:
ﬂuorescence images of NHBE dual-labelled for intracellular Nlrp3
andIL-1β.Bottom:quantitation of ﬂuorescence intensityby ImageJ
software showing statistically signiﬁcant increase (P<0.05),
when normalized to untreated controls, of both Nlrp3 and IL-1β
in cells stimulated with LPS, or IFN + LPS combination. Error
bars represent SEM. Expression of NRLP3 and IL1β was highly
correlated within individual cells (r = 0.73, Spearman Rank
correlation). Images are representative of 2 experiments with 30–
50 cells analysed for each treatment.
an important sentinel in the innate immune response and is
primed for a rapid response when exposed to danger signals
but has yet to undergo inﬂammasome activation.
Studies in cells of monocytic lineage have shown that
to mount a proinﬂammatory response, the inﬂammasome
pathway works in synergy with receptors for pathogen-asso-
ciated molecular patterns (PAMPs) and danger-associated
molecularpatterns(DAMPs),thebestcharacterizedofwhichJournal of Allergy 11
are TLRs. Thus, cell lines in their normal state usually do not
e x p r e s sp r e c u r s o r so fI L - 1 β and IL-18; production, matura-
tion, and extracellular release of these potent proinﬂam-
matory cytokines require at least two signals [7]. Ligation
of TLRs leads to enhanced transcription of the IL-1β gene
and accumulation of an immature form of IL-1β in the
cytoplasm. Stimulation with substances such as extracellular
ATP or uric acid leads to a second signal that results in cas-
pase-1 activation, processing of pro-IL-1β, and release of the
mature cytokine. Using antibodies that detect the presence
of neoepitopes in the caspase-1 subunits which become ac-
cessible only upon cleavage/activation of the proenzyme and
a blocking peptide, we were able to provide qualitative evi-
dence for presence of active caspase-1 in the airway epithe-
lium of the OVA-treated mice.
We also found, in these OVA-treated mice, a potentially
interesting and novel phenomenon of subcellular transloca-
tion for epithelial IL-1β, IL-18, and caspase-1, whereby these
molecules were seen to be concentrated at the epithelial api-
cal surface and apparently shed into the airway lumen in the
formofcellbodies.Thesigniﬁcanceofthisisunclearbutmay
provide a mechanism for release of inﬂammasome-relevant
molecules into the mucosa. IL-1β and IL-18 are proteins
without a signal sequence [24]. The precursors accumulate
in the cytosol following translation and a second signal is
required for caspase-1-mediated cleavage of the precursors
to the mature form that is released from the cell. Various
mechanisms for release of the active IL-1 cytokines (and cas-
pase-1, itself) have been postulated, including preexport into
secretorylysosomesorencapsulationinmicrovesiclesorexo-
somes [25]. Evidence for release as cell bodies or smaller
vesicles has been provided by studies in monocytes [24, 26],
microglia[27],anddendriticcells[28].Theclinicalrelevance
of the luminal shedding of the IL-1 cytokines is yet to be
explored.
Our ﬁndings support the notion that the airway epithe-
liumcanitselfmountaproinﬂammatoryresponseviaactiva-
tion of its inﬂammasome complexes and consequent release
of IL-1β and IL-18. We were able to detect high levels of
IL-1β in the circulation but not in the BALF. The reason
for failure to detect the IL-1-like cytokines in BALF may be
a consequence of dilution of apical secretions during our
lavage procedure (total wash volume was 3mL) or may be
because the time interval between ﬁnal OVA challenge and
BALFcollection(22hr)resultedinmissingthepeakcytokine
response. Relevant to this, 4 of the 8 OVA-treated mice had
highlevelsofIL-1β andTNF-αintheirserumwhiletheother
4 mice (like all of the control mice) had very low levels of
both cytokines, despite all 8 OVA-treated mice having high
levelsofairwayinﬂammationasevidencedbyeosinophiliain
BALF and tissues as well as epithelial swelling and cell death.
Our immunoﬂuorescence studies also suggested that other
potential sources of IL-1-like cytokines are eosinophils, alve-
olar macrophages, type II alveolar cells, and endothelium.
Relevant to our ﬁnding of NRLP3 in the normal mouse
bronchiolar epithelium is the recent observation reporting
NRLP3 and two other NLRs (NOD1 and NOD2) in upper
airway human tissues including normal nasal mucosa, nasal
polyps, tonsils, and adenoids [29]. It is likely therefore that
inﬂammasome components are present along the entire
length of the airways and constitute a front-line defence.
Their involvement in allergic and inﬂammatory diseases
of the airways such as chronic rhinosinusitis, rhinitis, and
asthma warrants further study.
A major limitation with studies of the whole lung is
that the lung is a complex organ comprising a number of
tissues. During airway inﬂammation, there is also substantial
inﬁltration of inﬂammatory cells, especially eosinophils. It is
therefore diﬃcult to interpret changes in gene expression at
the level of a single cell type in the lung. Because of this we
were driven from the start at establishing the techniques to
show the presence of inﬂammasome components in speciﬁc
cell types of the lung at a histochemical level. We think this is
a major advantage of our study.
Our initial attempt to look at changes in expression of
inﬂammasome-related genes in the context of murine airway
inﬂammation showed a large increase in expression of the
caspase inhibitor and inﬂammasome-binding protein NAIP
as well as decreases in expression of IL-18 and NRLP3.
Decreases in NRLP3 and IL18 gene expression during airway
inﬂammation may indicate the existence of a negative
feedbackmechanism.SinceNAIPisalsoabletosubstitutefor
NRLP3 and other NRLs in formation of the inﬂammasome
complex [30], there may be a switch from NRLP3 to NAIP
as a result of the inﬂammation. Discordance between mRNA
and protein expression of P2X7 receptor, an important up-
stream regulator of the NRLP3 inﬂammasome, has also been
reportedininﬂamedintestinalepitheliumfrompatientswith
inﬂammatory bowel disease [31]. In that study, in which
P2X7 receptor engagement was required for production
and release of IL-1β,m R N Al e v e l sf o rP 2X7 receptor were
increased while protein levels were strongly decreased. The
decrease in protein levels was much greater in patients with
active disease compared to those with quiescent disease and
correlated with the degree of polymorphonuclear inﬁltration
into the epithelium (transepithelial migration). The authors
speculated that the decrease in protein expression may
help to protect the intestinal epithelial cells from excessive
activation of P2X7 receptor and subsequent cell death during
the neutrophil transmigration. Eosinophilic inﬁltration into
the airway epithelium is also important in the pathogenesis
of asthma [32]. Downregulation of NRLP3 protein may have
a similar protective role against inﬂammation-associated cell
death during episodes of asthma.
Dissection of the mechanisms involved in airway epithe-
lial inﬂammasome regulation and activation will require the
use of in vitro airway epithelial cultures. We have shown
that the presence of NRLP3 and Il-1β proteins in the
commercially available normal human bronchial epithelial
primary cells and the 2–5-fold upregulation of these proteins
following priming with LPS indicates involvement of TLR4
in the priming. Another proinﬂammatory stimulus INFγ
which acts via a distinct signalling pathway was ineﬀective.
Inconclusion,wehavedemonstratedthepresenceofpre-
cursor components of the NRLP3 inﬂammasome in healthy
murine airway epithelium as well as changes in the subcel-
lular distribution of these components and appearance of
active caspase-1 in the epithelium of inﬂamed airways. At12 Journal of Allergy
this stage we know little about the extent to which the in-
nateimmunesystemandinﬂammasomeactivationinpartic-
ularexertprotectiveordetrimentaleﬀectsinasthma.Further
studies using both lung biopsies from patients and mecha-
nistic studies in polarized cultures of human airway epithe-
lium are warranted and may reveal new insight into the dis-
ease mechanism and additional targets for therapeutic
and/or diagnostic applications in asthma.
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